Skip to content

Effect of flumazenil on recovery quality of patients after induced abortion in painless clinic

Effect of flumazenil on recovery quality of patients after induced abortion in painless clinic

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049443
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless induced abortion

Interventions

Control group:propofol +normal saline
Experimental group:propofol +Flumazenil

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I~II; aged 18 to 50 years; 2. Painless abortion surgery to relieve the curse; 3. Be informed about all the contents of this study and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with obvious respiratory, circulatory dysfunction, abnormal blood routine and blood biochemical indexes before surgery; 2. Patients with severe neuropsychiatric diseases; 3. Those suffering from infectious diseases; 4. Those who take benzodiazepines or opioids intermittently every day within 1 month or within the past 3 months; 5. Those who are allergic or contraindicated to benzodiazepines, opioids, propofol and other drugs and their components; 6. Patients who are judged to have difficulty in airway management: modified Markov score grade III and above; 7. Patients who are participating in other clinical trials; 8. The researchers believe that patients should not participate in this trial.

Design outcomes

Primary

MeasureTime frame
Postoperative quality recover scale; state of out of bed ;

Secondary

MeasureTime frame
Eye opening time;Time to answer questions;Completion instruction time;Out of bed time;

Countries

China

Contacts

Public ContactLi Tingyi

First Hospital of Shanxi Medical University

499717232@qq.com+86 18780755162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026